http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2012244210-B2
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3284d6d12a6fba3c59f1ba057518cf83 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate | 2012-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cb5d37f42905275eca4d3fcbef63231 |
publicationDate | 2014-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | AU-2012244210-B2 |
titleOfInvention | Systemic treatment of metastatic and/or systemically-disseminated cancers using gm-csf-expressing poxviruses |
abstract | The present invention concerns methods and compositions for the treatment of cancer and cancer cells using intravascular administration of a vaccinia virus. In some embodiments, methods and compositions involve a replicative vaccinia virus that encodes GM-CSF. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105658795-B |
priorityDate | 2005-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1751.